With an increasing number of new drugs under development containing highly potent APIs, JM is able to combine our extensive technical expertise with specialised equipment in order to produce and handle them safely.
- Highly potent APIs to SafeBridge®4
- Containment practices effectiveness
- Isolator suite: OEL as low as 0.01 μg/m3
- Pilot plant: OEL as low as 1 μg/m3
- SafeBridge® Surrogate Sampling